Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae

被引:0
|
作者
Markland, W [1 ]
Petrillo, RA [1 ]
Fitzgibbon, M [1 ]
Fox, T [1 ]
McCarrick, R [1 ]
McQuaid, T [1 ]
Fulghum, JR [1 ]
Chen, WY [1 ]
Fleming, MA [1 ]
Thomson, JA [1 ]
Chambers, SP [1 ]
机构
[1] VERTEX PHARMACEUT INC, CAMBRIDGE, MA 02139 USA
来源
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
cDNA encoding the putative core of the hepatitis C virus NS3 serine protease domain (residues 1-181 of NS3; NS3(181)) was expressed as an N-terminally (His)(6)-tagged fusion protein in Saccharomyces cerevisiae. NS3(181) protease activity was found in soluble cell lysates, and the N-terminal metal-chelating domain facilitated the efficient purification of active enzyme, using immobilized metal affinity chromatography. The purified NS3(181) protease activity was characterized by assaying the trans-cleavage of in vitro transcription-translation generated substrates, and subsequently a previously unobserved cleavage site within the NS5A region was identified. The inhibitory effect of known protease inhibitors was also examined. It is hoped that availability of this method for the expression and purification of the NS3(181) protease will facilitate the development of anti-hepatitis C therapies.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [1] Substrate specificity of the hepatitis C virus serine protease NS3
    Urbani, A
    Bianchi, E
    Narjes, F
    Tramontano, A
    DeFrancesco, R
    Steinkuhler, C
    Pessi, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (14) : 9204 - 9209
  • [2] Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease
    Zhang, RM
    Durkin, JP
    Windsor, WT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1005 - 1008
  • [3] Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex
    Sali, DL
    Ingram, R
    Wendel, M
    Gupta, D
    McNemar, C
    Tsarbopoulos, A
    Chen, JW
    Hong, Z
    Chase, R
    Risano, C
    Zhang, RM
    Yao, NH
    Kwong, AD
    Ramanathan, L
    Le, HV
    Weber, PC
    BIOCHEMISTRY, 1998, 37 (10) : 3392 - 3401
  • [4] NS3 Serine Protease as a Target for Anti-Hepatitis C Virus
    Saleh, Noha A.
    Elshemey, Wael M.
    Elsayed, Anwar A.
    Ibrahim, Medhat
    REVIEWS IN THEORETICAL SCIENCE, 2015, 3 (03) : 257 - 263
  • [5] Detection and analysis of hepatitis C virus NS3 serine protease inhibitors
    Zemel, R
    Bachmatove, L
    Berdichevsky, Y
    Kunin, M
    Golan-Goldhirsh, A
    Benhar, I
    Tur-Kaspa, R
    JOURNAL OF HEPATOLOGY, 2001, 34 : 126 - 127
  • [6] The quest for hepatitis C virus NS3 serine protease inhibitors.
    Tur-Kaspa, R
    Berdichevsky, Y
    Zemel, R
    Bachmatov, L
    Lamed, R
    HEPATOLOGY, 2000, 32 (04) : 562A - 562A
  • [7] Cell transformation induced by hepatitis C virus NS3 serine protease
    Zemel, R
    Gerechet, S
    Greif, H
    Bachmatove, L
    Birk, Y
    Golan-Goldhirsh, A
    Kunin, M
    Berdichevsky, Y
    Benhar, I
    Tur-Kaspa, R
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (02) : 96 - 102
  • [9] Hepatitis C virus NS3 serine protease as a drug discovery target
    McPhee, F
    Yeung, KS
    Good, AC
    Meanwell, NA
    DRUGS OF THE FUTURE, 2003, 28 (05) : 465 - 488
  • [10] IDENTIFICATION OF THE PROTEASE DOMAIN IN NS3 OF HEPATITIS-C VIRUS
    HAN, DS
    HAHM, B
    RHO, HM
    JANG, SK
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 985 - 993